Cargando…

Mesenchymal stem cells in systemic sclerosis therapy

Systemic sclerosis (SSc) is a rare autoimmune disorder with a high mortality rate. There are still many unknowns concerning the pathophysiology of this disease, due to its clinical heterogeneity. Since there is still no curative treatment, researchers focus on finding novel methods to help the patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dudek, Daniel Witold, Walczuk, Ewa, Wajda, Anna, Paradowska-Gorycka, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2020
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667949/ https://www.ncbi.nlm.nih.gov/pubmed/33227099 http://dx.doi.org/10.5114/reum.2020.99995

Ejemplares similares

The Serum Cell-Free microRNA Expression Profile in MCTD, SLE, SSc, and RA Patients
por: Stypinska, Barbara, et al.
Publicado: (2020)

How the gut microbiota contributes to changes of autoimmune phenotype – from molecular studies to clinical utility
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2020)

Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement
por: Wajda, Anna, et al.
Publicado: (2022)

Cell Cultures as a Versatile Tool in the Research and Treatment of Autoimmune Connective Tissue Diseases
por: Ejma-Multański, Adam, et al.
Publicado: (2023)

Application of NGS Technology in Understanding the Pathology of Autoimmune Diseases
por: Wajda, Anna, et al.
Publicado: (2021)

AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients
por: Wajda, Anna, et al.
Publicado: (2021)

Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD)
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2019)

Epigenetic Regulations of AhR in the Aspect of Immunomodulation
por: Wajda, Anna, et al.
Publicado: (2020)

Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
por: Haładyj, Ewa, et al.
Publicado: (2016)

miR-10 and Its Negative Correlation with Serum IL-35 Concentration and Positive Correlation with STAT5a Expression in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2022)

The Interplay between Transcriptional Factors and MicroRNAs as an Important Factor for Th17/Treg Balance in RA Patients
por: Kmiołek, Tomasz, et al.
Publicado: (2020)

Th17/Treg-Related Transcriptional Factor Expression and Cytokine Profile in Patients With Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2020)

U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue disease Part I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease
por: Paradowska-Gorycka, Agnieszka
Publicado: (2015)

U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue disease Part II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease
por: Paradowska-Gorycka, Agnieszka
Publicado: (2015)

Expression of Prostaglandin Genes and β-Catenin in Whole Blood as Potential Markers of Muscle Degeneration
por: Wajda, Anna, et al.
Publicado: (2023)

The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus
por: Rzeszotarska, Ewa, et al.
Publicado: (2020)

Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus
por: Stypińska, Barbara, et al.
Publicado: (2015)

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
por: Wysocki, Tomasz, et al.
Publicado: (2022)

The role of cell-free circulating microRNA in diagnostics in patients with rheumatoid arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Personalized medicine in rheumatology
por: Kłak, Anna, et al.
Publicado: (2016)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
por: Kmiołek, Tomasz, et al.
Publicado: (2022)

Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis–From Research to Clinical Practice
por: Wysocki, Tomasz, et al.
Publicado: (2020)

Lack of significant association between selected STAT3 polymorphisms and rheumatoid arthritis in the Polish population
por: Stypińska, Barbara, et al.
Publicado: (2018)

Mixed Connective Tissue Disease as Different Entity: Global Methylation Aspect
por: Filipowicz, Gabriela, et al.
Publicado: (2023)

The level of TGF-β in sera of patients with primary Sjögren’s syndrome
por: Maślińska, Maria, et al.
Publicado: (2019)

Aging and the impact of global DNA methylation, telomere shortening, and total oxidative status on sarcopenia and frailty syndrome
por: Kmiołek, Tomasz, et al.
Publicado: (2023)

Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis
por: Xiao, Juan, et al.
Publicado: (2015)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2021)

Interleukin-21 gene polymorphism rs2221903 is associated with disease activity in patients with rheumatoid arthritis
por: Malinowski, Damian, et al.
Publicado: (2017)

Association study between immune-related miRNAs and mixed connective tissue disease
por: Stypińska, Barbara, et al.
Publicado: (2021)

Significance of Omega-3 Fatty Acids in the Prophylaxis and Treatment after Spinal Cord Injury in Rodent Models
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
por: Alanazi, Asma, et al.
Publicado: (2022)

FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2017)

RORC2 Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

SLC22A5 polymorphism associated with risk of extra-articular manifestations in rheumatoid arthritis patients
por: Pawlik, Andrzej, et al.
Publicado: (2019)

VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
por: Pawlik, Andrzej, et al.
Publicado: (2020)

Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2023)

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Islam, Md Asiful, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cr374o1csaqvvtqglg4kd4o5j0